In the News
In the News
AOTI Participates in Panel Discussion at Preventing Diabetes-Related Amputations in America
OCEANSIDE, Calif., July 14, 2023 /PRNewswire/ -- AOTI Inc., the global leader in multimodality topical wound oxygen therapy, participated as a founding member of the Amputation Prevention Alliance (APA), in the "Preventing Diabetes-Related Amputations in America: A...
The Most Positive Thing to Happen to Negative Pressure Wound Therapy
OCEANSIDE, Calif., June 7, 2023 /PRNewswire/ -- AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from ongoing WOCNext conference in Las Vegas, Nevada, where their game changing NEXA Negative Pressure Wound Therapy (NPWT)...
Topical Oxygen Therapy Awarded Positive Treatment Recommendation by the International Working Group on the Diabetic Foot in their 2023 Diabetic Foot Ulcer Guidelines
AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium on the Diabetic Foot (ISDF). The IWGDF has recognized the efficacy of topical oxygen therapy in their 2023 Diabetic Foot Ulcer Guidelines, further endorsing AOTI Inc.’s innovative treatment approach.
Topical Oxygen Therapy Awarded “A” Grade Treatment Recommendation by the American Diabetes Association in their 2023 Standards of Care in Diabetes
OCEANSIDE, Calif., Dec. 13, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that the American Diabetes Association has awarded an "A" grade recommendation for utilizing...
AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population
OCEANSIDE, Calif., March 23, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly...
Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation
OCEANSIDE, Calif., Feb. 14, 2022 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of...
Durable Healing Outcomes of Topical Wound Oxygen (TWO2) Therapy Highlighted at Leading International Clinical Conferences
OCEANSIDE, Calif., Aug. 26, 2021 /PRNewswire/ -- Advanced Oxygen Therapy Inc. (AOTI) announced today that its unique multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences across the United...
2,000,000 TWO2 Treatments Milestone Reached as TWO2 Study Is Highlighted in Systemic Review of Topical Oxygen Therapies
The addition of a new larger extremity-chamber to the company’s peripheral vascular disease (PVD) focused product line, allows for the application of TWO2 treatments for many more patients suffering from costly nonhealing chronic wounds.
Dr. Mike Griffiths, President and CEO of Advanced Oxygen Therapy, Inc makes the cover of Healthcare Insights.
The cover story, “Advanced Oxygen Therapy, Inc: Dedicated To Resolving Acute And Chronic Wounds Through Its Unique Multi-Modality Two2 therapy,” details the company’s mission as it fights to help patients with chronic wounds.